Who invested in Xylyx Bio

One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$2.5Mraised across 1 round since 2024, from 1 source

Latest round: Grant, $2.5MSept 2024
Investors: 3

See who backed them

The rounds

Sept 2024
Grant$2.5M
Source recorded

Founders and team

From Xylyx Bio's own website: 1 founder, 5 on the team.

John O’NeillChief Scientific Officer, Co-Founder, Board Director

Andrea NyeChief Executive Officer, President, Board Director
Anthony CurroBoard Chair & Interim Chief Financial Officer
Andrew SchmidtResearch Scientist
Jeffrey WuR&D Process Engineer, Matrix Platform
Jeremy GarciaResearch Scientist, Matrix Platform

Everyone who backed them

National Institutes of HealthGovernment1round

National Cancer Institute (NCI)Investment firm1round

National Heart, Lung and Blood InstituteVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Xylyx Bio as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

Boston Harbor AngelsAngel networkPer its own site

Quick answers about Xylyx Bio

Who invested in Xylyx Bio?

Xylyx Bio's investors include National Institutes of Health, National Cancer Institute (NCI) and National Heart, Lung and Blood Institute.

How much has Xylyx Bio raised?

Xylyx Bio has raised $2.5M across 1 round since 2024.

When did Xylyx Bio last raise?

Xylyx Bio's most recent round was a Grant of $2.5M in Sept 2024.

What was Xylyx Bio's biggest round?

Its most recent round, $2.5M in Sept 2024, is also its largest on record.

Who backed Xylyx Bio first?

Xylyx Bio's first round on record, in Sept 2024, was backed by National Institutes of Health, National Cancer Institute (NCI) and National Heart, Lung and Blood Institute.